86 related articles for article (PubMed ID: 872116)
1. Biochemically detectable tumor markers in urine of bladder cancer patients.
Irving CC
Cancer Res; 1977 Aug; 37(8 Pt 2):2872-4. PubMed ID: 872116
[TBL] [Abstract][Full Text] [Related]
2. Nucleoside excretion in breast cancer: comparison with other biochemical tumour-index-substances.
Coombes RC; Powles TJ; Gehrke CW; Waalkes TP; Neville AM
Invest Cell Pathol; 1979; 2(1):11-4. PubMed ID: 511604
[TBL] [Abstract][Full Text] [Related]
3. Urinary pseudouridine and beta-aminoisobutyric acid in patients with low grade urothelial tumours. Relations between excretion and tumour recurrence.
Nyholm KK; Sjolin KE; Wolf H; Hammer M; Knudsen J; Stahl D; Nielsen HR
Biomedicine; 1976 May; 25(3):85-7. PubMed ID: 949520
[TBL] [Abstract][Full Text] [Related]
4. A study on the clinical significance of urinary beta-aminoisobutyric acid in patients with urothelial tumours.
Nyholm KK; Sjölin KE; Hammer M; Knudsen J; Stahl D; Nielsen HR
Biomedicine; 1975 Nov; 22(6):509-16. PubMed ID: 1225382
[TBL] [Abstract][Full Text] [Related]
5. Excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the upper urinary tract.
Kvist E; Sjølin KE; Iversen J
Scand J Urol Nephrol; 1990; 24(4):287-92. PubMed ID: 2274753
[TBL] [Abstract][Full Text] [Related]
6. A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breast.
Woo KB; Waalkes TP; Ahmann DL; Tormey DC; Gehrke CW; Oliverio VT
Cancer; 1978 May; 41(5):1685-703. PubMed ID: 348295
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the urinary bladder.
Kvist E; Sjølin KE; Iversen J; Nyholm K
Scand J Urol Nephrol; 1993; 27(1):45-53. PubMed ID: 8493467
[TBL] [Abstract][Full Text] [Related]
8. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
[TBL] [Abstract][Full Text] [Related]
9. A diagnostic-prognostic test for bladder cancer using a monoclonal antibody-based enzyme-linked immunoassay for detection of urinary fibrin(ogen) degradation products.
McCabe RP; Lamm DL; Haspel MV; Pomato N; Smith KO; Thompson E; Hanna MG
Cancer Res; 1984 Dec; 44(12 Pt 1):5886-93. PubMed ID: 6498846
[TBL] [Abstract][Full Text] [Related]
10. Pseudouridine and beta-aminoisobutyric acid excretion in urine: diagnostic and prognostic value.
Kvist E; Sjølin KE
Scand J Urol Nephrol; 1990; 24(4):283-5. PubMed ID: 2274752
[TBL] [Abstract][Full Text] [Related]
11. Analytic techniques in the separation and identification of specific purine and pyrimidine degradation products of tRNA: application to urine samples from cancer patients.
Mrochek JE; Dinsmore SR; Waalkes TP
J Natl Cancer Inst; 1974 Dec; 53(6):1553-63. PubMed ID: 4474409
[No Abstract] [Full Text] [Related]
12. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer.
Waalkes TP; Gehrke CW; Zumwalt RW; Chang SY; Lakings DB; Tormey DC; Ahmann DL; Moertel CG
Cancer; 1975 Aug; 36(2):390-8. PubMed ID: 1157009
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of beta-aminoisobutyrate and pseudouridine in acute and chronic myeloid leukemia.
Nielsen HR; Killmann SA
J Natl Cancer Inst; 1983 Nov; 71(5):887-91. PubMed ID: 6580488
[TBL] [Abstract][Full Text] [Related]
14. Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract.
Koshida K; Harmenberg J; Stendahl U; Wahren B; Borgström E; Helström L; Andersson L
Urol Res; 1985; 13(5):213-8. PubMed ID: 4060364
[TBL] [Abstract][Full Text] [Related]
15. Urine based markers of urological malignancy.
Konety BR; Getzenberg RH
J Urol; 2001 Feb; 165(2):600-11. PubMed ID: 11176445
[TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of methylated nucleosides and pseudouridine in urine by gas-liquid chromatography.
Chang SY; Lakings DB; Zumwalt RW; Gehrke CW; Waalkes TP
J Lab Clin Med; 1974 May; 83(5):816-30. PubMed ID: 4821860
[No Abstract] [Full Text] [Related]
17. Beta-aminoisobutyric acid in urine from patients with urothelial tumours.
Nielsen HR; Nyholm K; Sjölin KE
Rev Eur Etud Clin Biol; 1971 May; 16(5):444-50. PubMed ID: 5113307
[No Abstract] [Full Text] [Related]
18. [Studies on urinary biochemical markers in patients with head and neck cancer: especially on polyamines, beta-aminoisobutyric acid and beta-alanine (author's transl)].
Hotate T
Nihon Jibiinkoka Gakkai Kaiho; 1981 Mar; 84(3):275-90. PubMed ID: 6788916
[No Abstract] [Full Text] [Related]
19. Effect of tryptophan and nicotinamide loads on urinary excretion of RNA metabolites by bladder cancer patients.
Nielsen HR; Wolf H; Brown RR
J Natl Cancer Inst; 1977 Sep; 59(3):855-8. PubMed ID: 142844
[TBL] [Abstract][Full Text] [Related]
20. Telomerase and other novel approaches to bladder cancer detection.
Bennett A
Clin Lab Sci; 2008; 21(3):185-90; quiz 191-2, following 192. PubMed ID: 18678141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]